Sunday, September 8, 2024
- Advertisement -spot_img

TAG

drugs

ARPA-H funding boosts Wyss Institute’s RNA therapeutic project

With the award for up to $27 million from the Advanced Research Projects Agency...

AI analysis of Reddit reveals public interest in GLP-1 drugs for weight loss and mental health benefits

In a recent study published in the journal Communications Medicine, researchers in...

New brain targets for GLP1-based obesity drugs may reduce weight without nausea

In a recent study published in the journal Nature, a group of...

Study reveals potential cognitive benefits of antidiabetic drugs

Investigators analyzing the potential cognitive effects of antidiabetic medications in records of...

Semaglutide Can Preserve, Possibly Improve, NYHA Functional Class in Obesity-Related HFpEF

Morten Schou, MD, PhDCredit: LinkedInAn analysis of the STEP-HFpEF program suggests use of semaglutide 2.4 mg (Wegovy) could help prevent deterioration, and possibly improve,...

Fungal endophytes: A promising frontier for breast cancer treatment

A recent Heliyon journal study discusses the role of fungal endophytes...

Blocking nidogen-2 enhances chemotherapy efficacy in pancreatic cancer

Researchers at the Garvan Institute of Medical Research have identified a potential...

Adult film star Jesse Jane’s cause of death revealed months after being found dead alongside boyfriend

Published 11:31 9 Jul 2024 GMT+1Adult industry star Jesse Jane's cause of death has been revealed by the Office of Chief Medical Examiner for...

Combining diabetes drugs offers heart, kidney benefits: study

Combined use of sodium glucose co-transporter 2 inhibitors (SGLT2is) and glucagon-like peptide-1 receptor agonists (GLP1-RAs) is likely to offer additional protection against heart and...

Clinical Quiz: Lifestyle and Nonpharmacological Interventions from ESC/EAS 2019 Dyslipidemia Guidelines

Few fields in cardiology have experienced the same level of change in recent years as lipidology. Driven by advances in pathophysiology as well as...

Exploring PRM-A as a novel glycan-targeted therapy for SARS-CoV-2 inhibition

HIV, Ebola and most recently, COVID-19 viruses have had an enormous impact...

SRI’s novel injectable formulation aims to provide a better option to fight malaria

SRI today announced that researchers are developing a new treatment that aims...

Latest news

- Advertisement -spot_img